Journal
FUNDAMENTAL & CLINICAL PHARMACOLOGY
Volume 30, Issue 5, Pages 483-485Publisher
WILEY
DOI: 10.1111/fcp.12213
Keywords
drug induced; idiopathic thrombocytopenia; influenza; oseltamivir; platelet count
Categories
Ask authors/readers for more resources
Oseltamivir is a neuraminidase inhibitor approved for the prevention and treatment of influenza. Few haematological side effects have been reported with oseltamivir. We report herein the case of an unexpected platelet increase in a 46-year-old woman with idiopathic thrombocytopenia (ITP) treated with oseltamivir for influenza. The mechanism may involve the neuraminidase inhibition which decrease platelet surface sialic acid content and reduce their removal by the reticuloendothelial system. Oseltamivir may be responsible for platelet increase especially in patients with ITP.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available